MedTrace Logo

Study to Estimate the Point Prevalence of Peripheral Intravenous Catheter-related Complications in Brazil

NCT03719287 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 295

Last updated 2024-10-02

Study results available
· View outcomes & findings →

Summary

A multi-center, national prevalence study where: (1) baseline SPIVC therapy complications of hospitalized adult patients that meet the inclusion/exclusion criteria of the study and (2) the compliance of clinicians to the Hospital's evidence based practice will be measured in Brazil.

Conditions

  • Infusion Site Injury

Sponsors & Collaborators

  • Eurotrials Brasil Consultores Cientificos Ltda

    collaborator INDUSTRY

  • 3M

    collaborator INDUSTRY

  • Solventum US LLC

    lead INDUSTRY

Principal Investigators

  • Joaquim Simoes Neto, MD · Centro de Pequisa Clinica Sao Lucas

  • Larissa S Victor, RN · Hospital Erasto Gaertner (HEG)

  • Ariane F Machado Avelar, PhD · Federal University of São Paulo

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-07
Primary Completion
2019-07-31
Completion
2019-10-01

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03719287 on ClinicalTrials.gov